News
17m
HealthDay on MSNMenopause Hormone Therapy Boosts GLP-1 Drug Effectiveness, Researchers SayKey Takeaways Menopause hormone therapy appears to boost the effectiveness of tirzepatide (Zepbound)Women lost more weight ...
A FAT jab user has revealed that after stopping the injections for eight weeks, she has now realised she is a “Mounjaro lifer ...
About one-third of Canadians have become obese — with more weight gain happening during the pandemic, according to a new ...
2h
Vietnam Investment Review on MSNWegovy® Now Available in Singapore for Weight ManagementSINGAPORE - Media OutReach Newswire - 12 July 2025 - A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company focused on defeating serious ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Danish pharmaceutical company Novo Nordisk has officially launched its once-weekly injectable weight management drug, Wegovy® (semaglutide 2.4mg), in Singapore. The treatment received regulatory ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results